drugset / Trial / NCT03041792

Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

NCT03041792

Phase 1 Completed 61 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

This will be a randomized, double blind, placebo controlled, 2 arm, parallel group, methodology study to assess the effect of 6 weeks of liraglutide administration on food intake in obese subjects.

Timeline

Start
2017-02-20
Primary completion
2018-01-16
Completion
2018-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide

Indications